Benzannulated Cyclooctanol Derivatives
FULL PAPER
Methyl trans-8-Hydroxy-8-methyl-5,6,7,8,9,10-hexahydrobenzocy- (2×s, 4 ×d, Ar), 76.6 (s, C-8), 42.8 (d, C-6), 40.1, 24.6 (s, q, tBu),
clooctene-6-carboxylate (43): 1H NMR (CDCl3, 200 MHz): δ = 39.2, 35.3, 33.0, 28.9 (4×t, 4×CH ) ppm. IR (KBr): ν = 3500 (br.,
˜
2
7.18–7.03 (m, 4 H, Ar), 3.71 (s, 3 H, CO2Me), 3.30–2.29 (m, 4 H, O–H), 3060–2860 (=C–H, C–H), 1715 (C=O) cm–1. C18H26O3
5-H, 6-H, 10-H), 2.71 (ddd, J = 3.6, 8.9, 14.1 Hz, 1 H, 10-H), 2.01–
1.54 (m, 5 H, 7-H, 9-H, OH), 1.21 (s, 3 H, Me) ppm. 13C NMR
(CDCl3, 50.3 MHz): δ = 176.1, 51.7 (s, q, CO2Me), 141.6, 137.2,
130.0, 129.3, 127.1, 126.7 (2×s, 4 ×d, Ar), 71.9 (s, C-8), 46.3, 38.6,
34.1, 29.3 (4×t, C-5, C-7, C-9, C-10), 42.7 (d, C-6), 34.6 (q, Me)
(290.4): calcd. C 74.45, H 9.02; found C 74.17, H 9.42.
SmI2-Induced Intramolecular Cyclization of 33a: The reaction was
performed as described in General Procedure 1, with 33a (0.220 g,
0.760 mmol), SmI2 (1.66 mmol), HMPA (2.42 g, 13.6 mmol) and
tBuOH (0.115 g, 1.55 mmol). The crude product was purified by
column chromatography (silica gel, ethyl acetate/hexane 10%) to
furnish 49 (12 mg, 6%, mixture of 2 diastereomers = 1:1), followed
by 47 (0.110 g, 50%) as colourless crystals (m.p. 80–81 °C).
ppm. IR (neat): ν = 3490 (O–H), 3100–2850 (=C–H, C–H), 1730
˜
(C=O) cm–1. MS (EI = 70 eV): m/z (%) = 248 (3) [M]+, 230 (10)
[M+ –H2O], 215 (8), 197 (17), 170 (32), 154 (23), 144 (100), 129
(26), 115 (42), 91 (29), 42 (28). C15H20O3 (248.3): calcd. C 72.55,
H 8.12; found C 72.39, H 7.91.
Methyl (4aSR,5SR,12aRS)-12a-Hydroxy-1,2,3,4,4a,5,6,11,12,12a-
decahydrodibenzo[a,e][8]annulene-5-carboxylate (47): 1H NMR
(CDCl3, 500 MHz): δ = 7.18–7.10, 6.97–6.96 (2×m, 3 H, 1 H, Ar),
3.75 (dd, J = 6.6, 14.9 Hz, 1 H, 6-H), 3.65 (s, 3 H, CO2Me), 3.18
(ddd, J = 3.5, 6.4, 17.3 Hz, 1 H, 11-H), 2.99 (ddd, J = 2.8, 6.6,
10.5 Hz, 1 H, 5-H), 2.91 (ddd, J = 3.6, 12.6, 17.3 Hz, 1 H, 11-H),
2.80 (dd, J = 2.8, 14.9 Hz, 1 H, 6-H), 2.57 (ddd, J = 3.5, 12.6,
15.0 Hz, 1 H, 12-H), 1.80 (ddd, J = 3.6, 6.4, 15.0 Hz, 1 H, 12-H),
1.72–1.60, 1.59–1.47, 1.39–1.25, 1.19–1.07 (4×m, 3 H, 3 H, 2 H, 1
H, CH, CH2) ppm. 13C NMR (CDCl3, 75.5 MHz): δ = 175.8, 51.0
(s, q, CO2Me), 139.6, 135.5, 132.3, 129.7, 126.6, 125.5 (2×s, 4 ×d,
Ar), 74.0 (s, C-12a), 48.1 (d, C-5), 42.5 (t, C-12), 41.1 (d, C-4a),
39.9 (t, C-1), 35.7 (t, C-6), 30.8 (t, C-11), 27.1, 24.9, 21.0 (3×t,
11-Methyl-12-oxatricyclo[9.2.1.03,8]tetradeca-3(8),4,6-trien-13-one
1
(46): H NMR (CDCl3, 200 MHz): δ = 7.25–7.12, 7.04 (m, d, J =
8 Hz, 3 H, 1 H, Ar), 3.30–3.16 (m, 3 H, 1-H, 2-H), 2.81–2.48, 2.32–
2.09, 2.03–1.52 (3×m, 2 H, 1 H, 3 H, 9-H, 10-H, 14-H), 1.40 (s, 3
H, Me) ppm. 13C NMR (CDCl3, 50.3 MHz) shows temperature-
dependent spectrum at room temp.; all signals except δ = 136.6 (s),
129.8 (d), 127.7 (d), 126.8 (d), 86.3 (s) appear as very broad signals;
measurement in [D6]DMSO as solvent at 80 °C showed all the sig-
nals clearly: δ = 178.4 (s, C-13), 141.1, 136.5, 130.5, 129.3, 127.0,
125.9 (2×s, 4 ×d, Ar), 85.5 (s, C-11), 41.7, 35.2, 34.7, 28.2 (4×t,
4×CH ), 29.3 (d, C-1) ppm. IR (gas-phase): ν = 3100–2850 (=C–
˜
2
H, C–H), 1795 (C=O) cm–1. MS (EI = 70 eV): m/z (%) = 216 (100)
[M]+, 159 (82), 129 (62), 115 (53), 115 (53), 104 (37), 91 (27), 43
(39). C14H16O2 (216.3): calcd. C 77.75, H 7.46; found C 77.68, H
7.31.
3×CH ) ppm. IR (KBr): ν = 3510 (br., O–H), 3060–2860 (=C–H,
˜
2
C–H), 1730 (C=O) cm–1. MS (EI = 70 eV): m/z (%) = 270 (84)
[M+ –18], 238 (50), 209 (44), 196 (100), 129 (81), 117 (65), 104 (45),
91 (47), 55 (26), 41 (23). C18H24O3 (288.4): calcd. C 74.97, H 8.39;
found C 74.97, H 8.65.
SmI2-Induced Intramolecular Cyclization of 30: The reaction was
performed as described in General Procedure 1, with 30 (0.210 g,
0.780 mmol), SmI2 (1.73 mmol), HMPA (2.53 g, 14.2 mmol) and
tBuOH (0.120 g, 1.64 mmol). The crude product was purified by
column chromatography (silica gel, ethyl acetate/hexane 10%) to
furnish 44 as a colourless oil (0.180 g, 84%).
3-(2-Vinylbenzyl)hexahydro-1-benzofuran-2(3H)-one (49): Mixture
of two diastereomers (1:1). 1H NMR (CDCl3, 200 MHz): δ = 7.49–
7.45, 7.25–7.04 (2×m, 1 H, 3 H, Ar), 6.97, 5.60, 5.29 (ABX system:
JAX = 17.3 Hz, JBX = 10.9 Hz, JAB = 1.4 Hz, 1 H each, CH=CH2),
4.55 (dd, J = 6.3, 10.6 Hz, 1 H, 4-H), 3.75–3.58, 3.46–3.12, 2.69–
2.45, 2.30–1.05 (4 ×m, 12 H, 2 ×CH, 5× CH2) ppm. 13C NMR
(CDCl3, 50.3 MHz): δ = 174.0, 164.0, 141.4, 137.7, 137.0 (5×s,
C=O, Ar), 135.4, 134.7, 130.2, 129.6, 129.5, 127.8, 127.0, 126.5,
122.2 (2×s, 7 ×d, Ar, =CH), 116.1, 101.5 (2×t, =CH2), 80.1, 49.7,
42.0 (3×d, CH), 39.4, 38.2, 34.3, 33.3, 28.0, 27.4, 27.1, 26.2, 26.0,
Methyl trans-8-Hydroxy-8-isopropyl-5,6,7,8,9,10-hexahydrobenzo-
cyclooctene-6-carboxylate (44): 1H NMR (CDCl3, 200 MHz): δ =
7.22–7.11, 7.10–7.02 (2×m, 3 H, 1 H, Ar), 3.70 (s, 3 H, CO2Me),
3.29 (dd, J = 5.5, 13.7 Hz, 1 H, 5-H), 3.08 (dd, J = 5.2, 13.7 Hz, 1
H, 5-H), 3.05–2.92 (m, 2 H, 10-H), 2.77–2.66 (m, 1 H, 6-H), 1.86–
1.73 (m, 4 H, 7-H, 9-H, OH), 1.55 (sept, J = 6.8 Hz, 1 H, CHMe2),
1.39 (dd, J = 12.3, 14.7 Hz, 1 H, 7-H), 0.86, 0.85 (2×d, J = 6.8 Hz,
3 H each, Me) ppm. 13C NMR (CDCl3, 50.3 MHz): δ = 176.3, 51.5
(s, q, CO2Me), 142.1, 137.3, 130.1, 129.2, 127.0, 126.5 (2×s, 4 ×d,
Ar), 75.0 (s, C-8), 42.6, 42.1 (2×d, C-6, CHMe2), 40.7, 34.5 (2×t,
C-5, C-10), 34.5, 28.7 (2×t, C-7, C-9), 17.0, 16.5 (2×q, CHMe2)
23.3, 22.8, 22.6 (12×t, CH ) ppm. IR (neat): ν = 3100–2850 (=C–
˜
2
H, C–H), 1795 (C=O) cm–1. MS (EI = 70 eV): m/z (%) = 256 (82)
[M]+, 238 (38), 183 (28), 159 (100), 129 (74), 117 (72), 104 (43), 91
(38), 41 (25).
Methyl 12a-Hydroxy-8,9-dimethoxy-1,2,3,4,4a,5,6,11,12,12a-deca-
hydrodibenzo[a,e][8]annulene-5-carboxylate (48): The reaction was
performed as described in General Procedure 1, with 34a (35 mg,
0.100 mmol), SmI2 (0.220 mmol), HMPA (0.330 g, 1.81 mmol) and
tBuOH (15 mg, 0.200 mmol). The crude product was purified by
flash chromatography (silica gel, ethyl acetate/hexane 15%) to fur-
nish 48 (25 mg, 71%) as a colourless oil and starting material 34a
ppm. IR (neat): ν = 3520 (br., O–H), 3060–2880 (=C–H, C–H),
˜
1730 (C=O) cm–1. C17H24O3 (276.4): calcd. C 73.88, H 8.75; found
C 73.02, H 8.63.
SmI2-Induced Intramolecular Cyclization of 31: The reaction was
performed as described in General Procedure 1, with 31 (0.190 g,
0.660 mmol), SmI2 (1.45 mmol), HMPA (2.12 g, 11.9 mmol) and
tBuOH (0.097 g, 1.32 mmol). The crude product was purified by
flash chromatography (silica gel, ethyl acetate/hexane 7%) to fur-
nish 45 (75 mg, 39%) as colourless crystals (m.p. 86–88 °C).
1
(10 mg, 28%). H NMR (CDCl3, 300 MHz): δ = 6.59, 6.45 (2×s,
1 H each, Ar), 3.84, 3.82 (2×s, 3 H each, ArOMe), 3.63 (s, 3 H,
CO2Me), 3.10 (ddd, J = 3.5, 6.4, 17.2 Hz, 1 H, 5-H), 2.95–2.77 (m,
2 H, 11-H), 2.71 (dd, J = 2.9, 15.1 Hz, 1 H, 6-H), 2.53 (td, J = 3.5,
Methyl trans-8-tert-Butyl-8-hydroxy-5,6,7,8,9,10-hexahydrobenzo- 15.1 Hz, 1 H, 6-H), 1.81–1.09 (m, 12 H, 4a-H, 11-H, OH, CH,
cyclooctene-6-carboxylate (45): 1H NMR (CDCl3, 300 MHz): δ = CH2) ppm. 13C NMR (CDCl3, 75.5 MHz): δ = 176.0, 51.2 (s, q,
7.20–7.11, 7.08–7.05 (2×m, 3 H, 1 H, Ar), 3.71 (s, 3 H, CO2Me), CO2Me), 147.4, 146.5, 131.5, 127.5, 115.5, 112.9 (4×s, 2 ×d, Ar),
3.22 (dd, J = 4.8, 13.8 Hz, 1 H, 5-H), 3.08 (dd, J = 6.7, 13.8 Hz, 1 74.1 (s, C-12a), 55.8, 55.7 (2×q, ArOMe), 48.4 (d, C-5), 42.3 (t,
H, 5-H), 2.95–2.74 (m, 3 H, 6-H, 10-H), 2.12 (dd, J = 2.5, 15.0 Hz, CH2), 41.2 (d, C-4a), 39.9 (t, CH2), 35.4 (t, C-12), 30.6, 27.2, 24.9,
1 H, 7-H), 1.91–1.86 (m, 2 H, 9-H), 1.41 (dd, J = 12.1, 15.0 Hz, 1 21.0 (4×t, 4×CH ) ppm. IR (neat): ν = 3525 (br., O–H), 2995–
˜
2
H, 7-H), 0.87 (s, 9 H, tBu) ppm. 13C NMR (CDCl3, 75.5 MHz): δ
2835 (=C–H, C–H), 1730 (C=O) cm–1. C20H28O5 (348.4): calcd. C
= 176.6, 51.7 (s, q, CO2Me), 141.9, 137.8, 130.1, 129.1, 127.2, 126.7
68.94, H 8.10; found C 68.71, H 8.42.
Eur. J. Org. Chem. 2006, 4419–4428
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4425